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Inserting Pharmacists in Primary Care
Roles in an Ambulatory Care Setting
KEITH YOSHIZUKA, PHARMD, MBA, JD, FCSHP, KATHERINE KNAPP, PHD
PATRICIA SHANE, PHD, MPH, DEBBIE LU, PHARMD, MPH

arely are health system administrators not concerned with finding adequate financial
resources to provide quality care to the communities they serve. The Patient Protec
tion and Affordable Care Act (PPACA) promises to bring more patients to hospital doors
while, at the same time, reducing reimbursement for their hospitalization costs. The Center
for Medicare and Medicaid Services (CMS) threatens reduced reimbursement for rehos
pitalization of patients within 30 days for similar diagnoses. To further exacerbate these
financial pressures, the lack of primary care physicians forces hospitals into competition
for physician services they can ill afford. What can be done?

R

In this report, we suggest how pharmacy personnel may be used to alleviate some of
the pressures currently impacting health system administrators. We look back to the
role(s) of the hospital pharmacy and the hospital pharmacist historically and outline
changes that have occurred and how these changes may be helpful to address several
problem areas in the ambulatory care venue.

Requests for Information:
Keith Yoshizuka, PharmD, MBA,
JD, FCSHP
Asst. Dean for Administration
Chair, Social, Behavioral, and Administrative
Sciences
Touro University - College o f Pharmacy
Keith.Yoshizuka@tu.edu

The American College of Clinical Pharmacy defines clinical pharmacy as “a health
science discipline in which pharmacists provide patient care that optimizes medication
therapy and promotes health, wellness, and disease prevention.”1Clinical pharmacists
assume responsibility and accountability for achieving therapeutic goals in all areas
of pharmacy including critical care, anticoagulation, cardiology, geriatrics, immu
nization, infectious disease, nephrology, neurology, pediatrics and oncology. They
serve as consulting pharmacists for long-term care facilities to ensure patients are
receiving optimal medication therapy. They manage patient therapy in direct patient
care settings working under protocol for conditions such as diabetes, anticoagulation
management, immunization, and oncology/chemotherapy management.
Hospital pharmacies were historically sites for procuring medications and managing
medication orders. Clinical pharmacy in hospitals was spawned by the expansion
of new and expensive medications and the need for monitoring medications with
possible serious side effects and/or very high costs. The clinical pharmacist often
needed to be at the bedside thereby moving pharmacy for the first time out of the
(usually) basement-based pharmacy and onto the hospital’s service units. The presence
of pharmacists “on the floors” has gradually led to integration of pharmacists into the
hospital healthcare team. A significant benefit of this shift is the presence in California
of a larger cohort of pharmacists with clinical skills who can be mobilized to fill new
roles that require clinical expertise.
Hospitals Utilization of Clinical Pharmacists: We now see smaller units, including
hospitals, building clinics that offer other out-of-hospital services for high risk patients
in order to make financially and clinically feasible strategies for sustained, successful
operation. The role of pharmacists in these expanded operations is one factor to be
considered as these models are rolled out. For example, in 2009 Jack et al piloted an
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Clinical pharmacy in
hospitals was spawned
by the expansion of
new and expensive
medications and the
need for monitoring
medications with
possible serious side
effects and/or very
high costs.

intervention at San Francisco General
Hospital and Trauma Center to test
the effects of a care transition program
designed to minimize hospital utiliza
tion after discharge. The intervention
included a clinical pharmacist calling
patients 2 to 4 days after discharge to
reinforce the discharge plan and review
medications. The authors found that
participants in the intervention had
a significantly lower rate of hospital
utilization and hospital utilization
cost savings that averaged $412 per
discharge as compared with those
receiving usual care.2 Kern Medical
Center’s utilization of clinical pharma
cists is another example of a community
hospital tapping into existing healthcare
resources to improve health outcome
and reduce healthcare cost. Kern
Medical Center is a 222-bed acute care
teaching hospital owned by Kern County
in Bakersfield, California. It has affili
ations with UCLA and UCI Schools of
Medicine and USC and UOP Schools of
Pharmacy. Pharmacists at this medical
center provide services including
diabetes management, anticoagulation
management, blood pressure manage
ment, oncology services, and smoking
cessation program. Overall, 32% of
patients in the Medicine Clinic are seen
by a clinical pharmacist. An evaluation
of the KMC’s Pharmacy Diabetes Clinic
indicated that the services provided by
clinical pharmacists assisted patients in
meeting clinical guideline for Ale, blood
pressure, and cholesterol level goals.3
Changes in the Hospital
Environment: The Emergence
of Clinics
The historic successful co-existence of
office-based physicians, medical groups
and hospitals was based on the ability of
each entity to succeed independently with
relatively non-binding relationships with
other entities. The emergence of health
plans and changes in reimbursement
structures forced hospitals to vertically
integrate, adding services such as clinics
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for patients with chronic illnesses in order
to retain a patient base. The emergence of
clinics to provide care for patients with
common, chronic medical conditions
like diabetes began, not surprisingly, in
organizations like the Veterans Admin
istration and Kaiser Permanente where
the organization had an obligation to
care for a defined population on a fixed
budget. These organizations were also
the first to place pharmacists in clinic
settings alongside physicians and nurses
to help patients maintain health and
avoid complications. These efforts were
successful and have become a permanent
feature of the care package. In a recent
publication by Hill et al, for example, the
authors described the comprehensive
ambulatory clinical pharmacy services
that are available at Kaiser Permanente
Colorado (KPCO).4 KPCO has approxi
mately 530,000 members and 150 clinical
pharmacists who provide clinical phar
macy services. The primary roles of the
clinical pharmacists in these settings were
to assist providers in optimizing medica
tion therapy to improve clinical outcomes
while minimizing the total costs of care.2
Clinical pharmacists at Kaiser Perma
nente work in a wide variety of service
areas including asthma/allergy, behav
ioral health, gastroenterology, infectious
disease, inpatient, nephrology, cardiology,
diabetes/endocrinology, dementia care,
and emerging area of continuing care.2,5
A 2011 Report to the Surgeon General
provided extensive documentation of the
value produced by pharmacists working
in clinic settings. Oncology is an area
where pharmacists have started their
services in the inpatient setting and tran
sitioned into the ambulatory care setting.
As oncology treatment migrated from
hospitals to infusion centers and other
ambulatory care settings, pharmacists
were hired into these outpatient settings
to prepare medications, dose, and manage
symptoms related to chemotherapy.
Today there are over 1,600 pharmacists
who are Board certified in oncology.7

Pharm acists in Prim ary Care

S a fe ty N e t C linics

One of the factors limiting the incor
poration of clinical pharmacists into
the multi-disciplinary care team in the
clinic setting is the financial burden, as
pharmacists are not reimbursed for their
services by third party payers. Recog
nizing the important role that clinical
pharmacists play in patients’ health,
particularly underserved populations
with complex medical conditions, many
colleges of pharmacy have developed
partnerships with community medical
clinics to enhance the pharmaceutical
care in these populations. Examples of
this include community partnerships
between the University of Southern
California School of Pharmacy and the
Los Angeles County community clinics,2
Touro University and San Francisco
General Hospital and Trauma Center,
LifeLong Medical Care, and Clinic Ole
in Napa. The pharmacists in these clinics
provide clinical services including, but
not limited to, a review of the patients
medication experience, updating
medication allergies and adverse reac
tions, reviewing medication history and
current medication record for indication
for use, product, dose, duration, and how
the medication is actually being taken.
Pharmacists also review active drug
therapy problem lists and therapeutic
treatment plans for appropriateness,
effectiveness, safety, and medication
adherence for vulnerable population in
safety net clinics.
C o n s id e r a tio n s f o r P la c in g
P h a rm a c is ts in A m b u la t o r y
C a re (a m c a re ) C lin ic s

Available evidence cited above suggests
that when a hospital decides to initiate
or expand ambulatory care clinics as
part of its service package, it is logical
to consider a role for pharmacists. The
principal issues to be considered when
moving in this direction are 1) financial
considerations and 2) establishing a
plan for introducing pharmacists into a
clinic model.

Median 2012 annual salaries before
benefits as reported by the Bureau of
Labor Statistics (BLS) are: physicians
($187,200), registered nurses ($65,470)
and pharmacists ($116,670).8’9,10 The
relatively high pharmacist salaries and
reimbursement issues (discussed in
other sections) have caused hospital
administrators and others to demand
financial justification for adding
pharmacists to clinics. While there is
abundant evidence of both financial and
clinical value of clinical roles for phar
macists in clinics; much of the evidence
comes from governmental or managed
care organizations. Different business
models and circumstances often make
this justification a required step prior
to adding pharmacists. Their justifica
tion is generally based on demonstrating
reduced overall patient utilization of
expensive services (hospital and emer
gency department use) and savings
on expensive medication use. Experi
menting with pharmacist roles is often
an initial step. Many organizations
experiment with new roles for pharma
cists by adding a pharmacy resident(s).
The resident’s salary cost is less (approxi
mately $46,000-$48,000 annual salary)
and residency training is highly oriented
to experimentation and data collection.
Pharmacy residencies generally last
one year—sufficient time to integrate
into a service and observe the impact.
There are many examples where datadriven, successful residencies result in
converting the residency position to
a staff position. (Residency training
programs are described below).
Generally, adding pharmacists to clinics
occurs in the setting of existing clinics
run by physicians overseeing nurses
who work directly with patients (case
management). Pharmacists are often
introduced into this traditional model
by initially working as a consultant to
the nurses for patients with complex
medication regimens. Gradually, the
pharmacist establishes an integrated
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role that is best described as a referral
role where both physicians and nurses
refer those cases where the pharmacist’s
expertise in medication management is
likely to improve patient outcomes.
Pharmacists have identified a niche
in managing chronic diseases treated
primarily with medication, diet, and
exercise (such as hypertension, diabetes,
and hypercholesterolemia); and
managing anticoagulant drug therapy.
Pharmacists have also played an impor
tant role in oncology through managing
chemotherapy, symptom management
support, pain management, assessment
of response and toxicities, and manage
ment of nausea and vomiting through
antiemetic therapy. This is contrasted
with the roles of nurse practitioners
and physician assistants who play major
roles in urgent care clinics, physical
assessment screenings, emergency
departments, and working with ortho
pedic surgeons.
A v a ila b ility o f A p p r o p r ia te ly
T ra in e d P e rs o n n e l: Can You
F ind th e R ig h t P eople?

There are approximately 35,000 licensed
pharmacists in California about 25% of
whom practice in hospitals (<9,000).11,12
The number of pharmacists already
working in clinics is unknown but likely
less than 3,000. California law requires
that in order to work in a clinic setting,
a pharmacist must have either success
fully completed a pharmacy residency or
have demonstrated clinical experience
in direct patient care delivery. Many
pharmacists who have worked in an
acute care setting in California have this
clinical experience through the protocols
of the hospital in managing the dosing of
various antibiotics, parenteral nutrition,
and anticoagulation therapies.
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R e s id e n c y -tra in e d
P h a rm a c is ts a n d
C e rtific a tio n in S p e c ia lty A reas

Nationally, there has been rapid growth
in pharmacy residencies. Based upon
2013 data, available through the Phar
macy Online Residency Centralized
Application System (PhORCAS), there
were over 1,600 residency programs that
collectively offered over 3,000 positions.
Despite the expansion of pharmacy
residencies there continues to be unmet
need, as evidenced by the volume of
individual PGY1 and PGY2 applications
(n=5,808) received that year, Pharmacy
residencies are defined as an organized,
directed, postgraduate training program
in a defined area of pharmacy practice.13
The majority of pharmacy residencies are
pursued immediately after graduation
from pharmacy school and last one year.
These residencies are identified as PostGraduate Year 1 (PGY1) residencies.
The American Society of Health-System
Pharmacists (ASHP) is the main accred
iting body for accrediting health-system
pharmacy residencies. Pharmacists who
complete an ASHP-accredited PGY1
residency or a residency with Candidate
status with ASHP are eligible to take
a Board of Pharmaceutical Specialties
(BPS) examination in Pharmacotherapy
that, if passed, identifies them as BPScertified in Pharmacotherapy.14The
Board-certified designation is helpful
to hospitals for internal credentialing,
credibility and comfort with assigning
clinical roles.
Specialty residencies—referred to as
PGY2 programs—offer additional
postgraduate training in areas such as
ambulatory care, critical care, psychiatry,
nutrition support, oncology and infec
tious disease. Pharmacists who complete
PGY2 residencies are eligible to take BPS
examinations in specialty areas. Current
areas of specialization include ambula
tory care, nuclear pharmacy, nutrition
support, oncology and psychiatric
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pharmacy. Pediatrics and critical
care have recently been added as BPS
specialties with certification examina
tions to begin in Fall 2015.15 Passing the
examination(s) qualifies the pharmacist
as BPS-certified in a specialty area. The
Board-certified specialty designation
is again helpful to hospitals for credentialing, credibility and comfort with
assigning clinical roles.
Residency programs can apply for
accreditation through the American
Society of Health-System Pharmacists
(ASHP). Accreditation implies that the
program has met ASHP standards for
residency training. Continued accredi
tation requires periodic re-application
and site visits. A listing of ASHPaccredited programs is available on
the ASHP website (http://accred.ashp.
org/ aps/pages/directory/residencyProgramSearch.aspx). Many residency
programs do not apply for ASHP accred
itation for a variety of reasons. There
is no reliable listing of non-accredited
programs but it is estimated that ASHPaccredited programs account for about
two-thirds of residencies.
Hospitals wishing to explore or start
residency programs can find help. ASHP
ofFers specific information about starting
residency programs.16 Many hospitals
will find willing partners in schools or
colleges of pharmacy. Pharmacy schools
make good partners for the research
projects that residents are required to
complete and pharmacy schools prefer
to have their students train in hospitals
where residency training is concurrent.
Professional meetings of ASHP, CSHP
and the American College of Clinical
Pharmacists (ACCP) almost always
include programming about starting and
managing residencies.
Whether PGY1 or PGY2, residents are
required to complete a research project.
These projects often present opportu
nities for hospitals to assess internal

processes regarding the use of medi
cations and to experiment with new
services, processes and procedures. An
example would be the initiation of a
new ambulatory clinic with pharmacists
participating on a medical team. Cali
fornia residents are required to present
their projects at the Western States
Residency Conference (www.westernstates-rx.org) which is held annually in
May. At the conference, hospitals and
clinics with residency programs have
the opportunity to identify “talent” in
specialized or general clinical areas.
California has always been a leading
state in providing residency-trained
pharmacists. In 2014, California had
approximately 1 2 1 accredited PGY1
programs and 33 accredited PGY2
programs. PGY2 specialty areas include
administration, ambulatory care,
cardiology, critical care, drug informa
tion, emergency medicine, infectious
diseases, oncology, pain management
and palliative care, pediatrics, pharmacy
informatics, psychiatry and solid organ
transplantation (data provided by ASHP,
2014). Many residency programs—PGY1
programs in particular—support more
than one resident.17The University of
Southern California, for example, has 4
PGY1 and 2 PGY2 residency programs
with over 40 residents annually. For
the 2013-14 year (July 1 to June 30),
there were about 314 pharmacists who
completed either PGY1 or PGY2 resi
dencies in California (data provided by
the California Society of Health-System
Pharmacists, 2014). Anecdotally, we
observe that the majority of Californiatrained pharmacists seek to remain in
California to practice.
L e g i s l a t iv e Is s u e s

As is often the case, the changes in
practice preceded changes in the law to
allow them to happen. This is not to say
that these pharmacists were operating
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outside of the law; only that the law was
silent on the matter because the existing
laws were developed before anyone had
envisioned such services. The California
legislature recognized this and promul
gated legislation to keep up with the
changing environment.
In California, a pharmacist in a medical
clinic who has successfully completed
clinical residency training or demon
strated clinical experience in direct
patient care delivery has been able to
legally adjust a patient’s drug regimen
per clinic approved protocol since 1996
(AB 2802 Granlund).18 In 1999, the law
was expanded such that a pharmacist
could adjust a patient’s drug regimen
pursuant to a protocol as part of the
care of a single physician (not neces
sarily restricted to a clinic setting) (AB
261 Lempert).19In 2001, that scope was
expanded to include initiating a drug
regimen, not restricted to adjusting a
drug regimen that had already been
commenced (AB 826 Cohn).20 In 2006,
the section of the Business & Profes
sions Code identifying this scope for
a pharmacist in a clinic setting was
renumbered to B&P §4052.2 (AB 2408
Negrete-McLeod).21
Examining the requirements for the
application of B&P §4052.2 dealing with
a pharmacist’s scope of practice in a
clinic setting, all of the procedures logi
cally involve patients on drug therapy or
who will receive drug therapy. Specifi
cally, a pharmacist may assess the drug
therapy, including ordering laboratory
tests, administer drugs and biologicals,
and initiate and adjust drug regimens
pursuant to an approved protocol. The
protocol must be developed by a multi
disciplinary team that includes both
physicians and direct care registered
nurses, who shall determine the breadth
and limitations of such protocol. The
protocol must require that the patient
must first have been seen by a physi
cian before referral to a pharmacist, and

that the scope of procedures performed
by the pharmacist must relate to the
condition for which the patient was first
seen by the physician. The protocol shall
require that the patient’s medical record
be accessible to both the pharmacist
and the physician, and that any change,
adjustment, or modification of an
approved pre-existing treatment or drug
therapy be provided in writing to the
treating or supervising physician within
24 hours.
In order for a pharmacist to be quali
fied to perform these functions in a
clinic setting under B&P §4052.2, the
pharmacist must have either success
fully completed a clinical residency
training program, or have demonstrated
clinical experience in direct patient care
delivery. Many of the pharmacists who
have worked in an acute care setting in
California have this clinical experience
through the protocols of the hospital
in managing the dosing of various
antibiotics, parenteral nutrition, and anti
coagulation therapies as described above.
In 2013, SB 493 (Hernandez) was
approved by the California legislature to
expand the scope of every pharmacist in
California to furnish hormonal-based
contraceptives, emergency contracep
tion, travel medications for international
travel, immunizations on the Centers
for Disease Control (CDC)-recommended schedule, and nicotine-based
smoking cessation aids, pursuant to
state approved protocols and subject
to specified training.22 In addition, the
bill created a new category of licensed
pharmacist known as an Advance
Practice Pharmacist (APP), who would
not necessarily be restricted to practice
within a hospital or clinic. In order to
qualify for licensure as an Advanced
Practice Pharmacist, the pharmacist
must have completed two of the three
following criteria:

continued on page 25
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4210(a) (2) (A): Earn board
certification,
4210(a) (2) (B): Complete a post-grad
uate clinical residency, and/or
4210(a) (2) (C): Have at least one year
of experience practicing as a clinical
pharmacist.
Under current law, there is no
requirement for a pharmacist working
in a clinic under B&P 4052.1 or
4052.2 to be licensed as an Advanced
Practice Pharmacist.
To date, the proliferation of clinical
pharmacists in the ambulatory care
(clinic) setting has occurred largely in
managed care organizations such as
Kaiser Permanente and the Veterans
Administration, since fee-for-service
reimbursement is not an issue in these
environments. A limiting factor outside
managed care is that pharmacists are
not yet recognized as providers under
Medicare Part B for reimbursement, so
services rendered by pharmacists in the
clinic are not reimbursable under Medi
care. HR 4190 was introduced into the
House of Representatives in Washington,
DC in March 2014 by Representatives
Bret Guthrie (R-Ky), G.K. Butterfield
(D-N.C.), and Todd Young (R-Ind), a
bill to amend the Social Security Act to
provide for coverage under the Medi
care program of pharmacist clinical
services.23 This bill would have allowed
pharmacists in the clinics to bill for
their services through Medicare Part B.
A recent letter from the Administrator
of CMS affirming that incident-to Part
B Medicare billing by physicians for
pharmacist-provided services is lawful
under specified conditions suggests the
CMS would not be opposed to such
legislation.24 Unfortunately, the term of
the 113th Congress ended before the
bill could be passed. Now that a new
session of Congress is underway, bills
have been introduced on both sides of
Congress to allow pharmacists to bill for
services under Medicare Part B in the

Senate under S 31425 and in the House of
Representatives under HR 59226. This is
encouraging since bills have been intro
duced in both the Senate and the House
of Representatives, and both appear to
have bipartisan support.

Implications of Healthcare Law
Changes for Hospitals
Healthcare law changes in 2013-2014
have the potential to trigger changes in
affordable care and spur development
of models that allow hospitals to utilize
staff more efficiently. Furthermore,
forecasts for meeting the demand for
primary care predict that primary care
physician shortages will increase dramat
ically by 2025, and there is growing
evidence that primary care shortages are
shifting the debate on expanding scopeof-practice laws.27 Given the current
mismatch with patient needs, emergency
room use for primary care problems is
on the rise in several regions, and health
care leaders in those markets believe
that is due to a shortage of primary
care physicians. The use of emergency
departments by Medicaid patients for
primary care services is a problem for
insurers who cover that population,
but it’s also an indication of what may
be ahead for privately insured patients,
who cannot get timely appointments
with primary care providers. Hospitals
in California are typically located where
people are located. The geographic
distribution indicates that hospitals
are primarily distributed in proportion
to the number of people, rather than
income. However, a recent analysis of
hospitals by population income in LA
County suggests that people who have
the least amount of money, may have
relatively easy geographic access to
hospitals but limited access to primary
care.28 Low income areas in California
may be surrounded by hospitals, but lack
primary care resources.
How pharmacists get reimbursed
directly affects the workforce and scope
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of practice. Payment policies have an
immediate effect that produces change
in the volume and type of care delivered.
Historically, health plans have been slow
to change the way they reimburse for
care. Increasingly, there is an impetus
to find reimbursement and workforce
mechanisms to prevent a diabetic from
requiring an amputation, rather than a
reimbursement schema that rewards an
orthopedic surgeon for the amputation.
In the absence of creating new efficien
cies to address physician shortages,
systemically, we could inadvertently
develop greater inefficiencies, such as
increases in emergency department
use, longer waiting times for appoint
ments, higher costs for imaging services
and pharmaceuticals, and utilization
of specialty care lacking coordination,
magnified by health reform driven
improved access to and demand for
needed health care.
H e a lth C are R e fo rm & P hysician
S h o rta g e s in C a lifo rn ia

The shortages in primary care physicians
are evident when mapped and indicate
that these short falls are a geographic
issue. Only 16 out of 56 California
counties have enough primary care
physicians.29 Effectively, when applied
to the resident population of the state,
less than one third of Californians live
in a place where access to primary
care physicians meets the needs of the
population.30 With increased demand
for health care services and a shortage of
physicians, the potential gaps in direct
patient care are likely to widen unless
alternatives are brought into play.
In California a “Bridging the Provider
Gap” campaign was initiated through
the coalition Californians for Acces
sible Healthcare (comprised of the
California Association for Health
System Pharmacists, the California
Society of Health System Pharmacists,
the California Optometric Association,

26 cjhp California Journal of Health-System Pharmacy Jan uary/F ebru ary 2015

and the California Pharmacists Asso
ciation). Effects of changes in health
system management hold the promise
of achieving efficiencies in staffing and
producing improvements in outcomes.
Almost 20 percent of Americans, 56
million people, have inadequate or
no access to primary care physicians
because of a shortage of providers, and a
majority of them are insured, according
to a report issued by the National
Association of Community Health
Centers and the American Academy
of Family Physicians.31 Multiple 2014
studies and surveys indicate that the
number of uninsured fell as a result of
expanded Medicaid eligibility and health
insurance exchanges established through
PPACA. Overall, RAND’s Health Reform
Opinion Study (HROS) in March 2014
estimated that 9.3 million more people
had health care coverage. The increase
was driven by enrollment in health
insurance marketplace plans and by
increases in employer-sponsored insur
ance and Medicaid enrollment increases.
Data from August 2014 showed that 7.3
million people had enrolled through the
marketplace and paid their premiums.32
B e h in d th e P hysician S h o rta g e s

The U.S., relative to other countries,
has low physician to population ratios.
The physician workforce is aging. The
population is aging and doctor visits
increase substantially for those over 65.
Equally important, the supply of new
primary care physicians is not sufficient.
Estimates are that new U.S. educated
physicians account for an increase each
year of about 1 percent of the current
primary care physician workforce.
First year MD enrollment in relation to
100,000 population has been in steady
decline since 1980. Limited residency
slots are a contributing factor. “In 1997,
the federal government essentially froze
spending on residency slots, limiting
the number to around 100,000 over

Pharm acists in Prim ary Care

three-to-four years, and in turn
freezing the number of newly licensed
physicians available for hire each
year to around 26,000.” While some
increases have resulted from hospitals
that have established new residency
programs for primary care doctors,
the volume is not sufficient, espe
cially given the estimated 50 million
person increase in the U.S. popula
tion during that time period. “The
American Association of Medical
Colleges estimates that the U.S. will
face a shortage of 46,000 primary care
doctors by 2020, equivalent to onequarter of everyone practicing in that
category today.”33
W o rk fo rc e a n d
C a p a c ity Issues

Around 2006, the concept of a U.S.
shortage of primary care physi
cians was first publicized.34 Roles
for advanced practice nurses and
physician assistants were emphasized
to “fill the gap”. Given the abun
dant research (see the Report to the
Surgeon General) that has shown the
value of pharmacists in ambulatory
and primary care activities—both
from an economical and from an
outcomes perspective, pharmacists
can contribute to “filling the gap”
created by the primary care physician
shortage.
With approximately 35,000 licensed
pharmacists in California about
25% of whom practice in hospitals
and of those who are hospital-based
less than half qualifying as clinical
pharmacists, there are less than 4,500
clinical pharmacists available for
implem enting or augmenting clinical
services in hospital or clinics in Cali
fornia today.
Nationally, hospital-based pharma
cists accounted for about 25% of total
pharmacy positions. Some of these
pharmacists typically have completed

one or more years of pharmacy
residency training which is focused
on higher levels of clinical skills and
experiences. Some hospitals separate
clinical pharmacists based on their
training and role from the rest of the
pharmacy staff while other hospi
tals find it more practicable to have
pharmacists able to perform both
traditional and newer clinical roles.
M o v in g F o rw a rd

Pharmacists are currently able to
legally function as mid-level prac
titioners in an ambulatory care
setting under approved protocols so
long as they have either (1) success
fully completed a clinical residency
training program, or (2) have demon
strated clinical experience in direct
patient care delivery. Hospitals and
health systems looking to insert clin
ical pharmacists into a medical clinic
setting may draw from their internal
resources as well as recruiting new
pharmacists with hospital experience,
taking those pharmacists who have
been functioning in the acute care
setting practicing direct patient care
delivery to those hospitalized patients
and providing them with the opportu
nity to practice in the ambulatory care
venue (the attraction of a Monday
through Friday stable work schedule
may be appealing). Even though the
number of pharmacy residencies is
increasing, only about half of those
pharmacists who apply actually get
accepted. One strategy to consider
is for hospitals to develop their own
pharmacy residencies with rotations
in the clinic. Using this strategy, the
facility gets a pharmacist (usually
licensed within 90 days of starting)
to train in both the hospital and the
clinic for less than half of what it
costs for a clinical pharmacist for a
year, and the opportunity to recruit
the resident when they complete the
one year program. The proliferation

of the use of pharmacists practicing
in the ambulatory care environment
has been hindered by the inability
to capture reimbursement for these
services; however the Affordable
Care Act (ACA) is presenting some
opportunities allowing pharma
cists to qualify for “incident-to”
billing just as much as other clinical
team members, so long as such
services are permitted under their
state license and that “medication
management services” (billing codes
99605-99607) are not covered under
Medicares Part B program, but are
instead billable under Medicare
Advantage or Part D medication
plan.35Another development is
HR 4190 introduced in Congress
earlier this year, which would allow
pharmacists in the clinics to bill for
their services through Medicare Part
B. This bill has bipartisan support
and is currently being heard in
committee in the House of Repre
sentatives in Washington, DC. Given
the current physician shortage, it
would make sense to expand the
use of pharmacists in primary care
clinics as mid-level providers to
manage chronic diseases such as
diabetes, hypertension, hyperlipid
emia, and other diseases managed
primarily with medications. O
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Figure 2. Distribution of Hospitals within California by
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